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INTRODUCTION
Acute lower gastrointestinal bleeding (LGIB) is a common 
presentation to the emergency department (ED) and requires 
hospitalization for up to 87 per 100,000 adults per year.1–3 
Mortality from LGIB can be up to 5%.4–10 Further, 20% will 
have recurrent bleeding while being hospitalized after a first 
LGIB episode,7,8,11,12 and as many as 24% of patients require an 
intervention to control the hemorrhage.4–8,11 Endoscopy plays a 
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Introduction: There are currently no robust tools available for risk stratification of emergency 
department (ED) patients with lower gastrointestinal bleed (LGIB). Our aim was to identify risk factors 
and develop a preliminary model to predict 30-day serious adverse events among ED LGIB patients.
Methods: We conducted a health records review including adult ED patients with acute LGIB. 
We used a composite outcome of 30-day all-cause death, recurrent LGIB, need for intervention 
to control the bleeding, and severe adverse events resulting in intensive care unit admission. One 
researcher collected data for variables and a second researcher independently collected 10% of the 
variables for inter-observer reliability. We used backward multivariable logistic regression analysis 
and SELECTION=SCORE option to create a preliminary risk-stratification tool. We assessed the 
diagnostic accuracy of the final model. 
Results: Of 372 patients, 48 experienced an adverse outcome. We found that age ≥75 years, 
hemoglobin ≤100 g/L, international normalized ratio ≥2.0, ongoing bleed in the ED, and a medical 
history of colorectal polyps were statistically significant predictors in the multivariable regression 
analysis. The area under the curve (AUC) for the model was 0.83 (95% confidence interval, 0.77-
0.89). We developed a scoring system based on the logistic regression model and found a sensitivity 
0.96 (0.90-1.00) and specificity 0.53 (0.48-0.59) for a cut-off score of 1.
Conclusion: This model showed good ability to differentiate patients with and without serious 
outcomes as evidenced by the high AUC and sensitivity. The results of this study could be used in 
the prospective derivation of a clinical decision tool. [West J Emerg Med. 2020;21(2)343-347.]
major role in the management of LGIB patients; however, there 
are limited resources for safe after-hours endoscopy in Canada.13 
Risk-stratification of LGIB patients in the ED could help identify 
patients who need urgent intervention and those who could be 
safely managed as outpatients. 
While several risk tools have been developed, most are 
not applicable to ED patients as they only include admitted 
patients and exclude patients who are discharged. Further, these 
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Population Health Research Capsule
What do we already know about this issue?
There are no robust risk tools to predict 
30-day adverse outcomes for emergency 
department (ED) patients with lower 
gastrointestinal bleed (LGIB).
What was the research question?
We sought to identify risk factors and develop 
a preliminary model to predict 30-day adverse 
outcomes in ED LGIB patients.
What was the major finding of the study?
We developed a preliminary model with five 
predictors that identifies ED LGIB patients at 
low-risk for 30-day adverse outcomes.
How does this improve population health?
Risk-stratification of ED LGIB patients could 
reduce the burden on the healthcare system 
and the associated healthcare costs.
studies have small patient cohorts, include a large number of 
predictor variables in their final model, and have a low diagnostic 
accuracy.8,9,14–19 Emergency physicians need a new decision tool 
that overcomes these limitations and will aid them in making 
evidence-based disposition decisions. The objective of this study 
was to identify risk factors for serious outcomes among ED 
patients with LGIB and to develop a preliminary model for a risk-
stratification tool to predict 30-day adverse events. 
METHODS
Study Design
This was a retrospective cohort study approved by the 
Ottawa Health Science Network Research Ethics Boards. The 
research ethics boards of the Queensway-Carleton Hospital 
approved the study protocol for health records review for patient 
follow-up and outcome ascertainment.
Study Setting and Population
We conducted the study at two tertiary-care EDs of the 
Ottawa Hospital among adult patients who presented with 
acute LGIB between August 2013–June 2014. Clinically, an 
acute LGIB was defined as bright red blood per rectum in the 
prior two days, bright red blood on the glove after digital rectal 
examination, or a clear red bloody stool during the ED visit. 
We identified potential eligible patients using International 
Classification of Disease, 10th Revision, codes related to 
LGIB. We excluded patients with the following characteristics: 
evidence of an upper gastrointestinal bleed without signs of a 
LGIB; patients who were already hospitalized; those designated 
palliative with less definitive interventions offered; LGIB 
secondary to a trauma; and patients who were not from the local 
area. We excluded multiple patient visits and only included the 
first visit for LGIB-related symptoms to the ED. 
Study Protocol
One investigator collected variables and outcomes using a 
standardized case record form. A second investigator collected 
data for 10% of a random selection of the total patient cohort. We 
calculated a ĸ-value for inter-observer reliability. 
Outcomes
The primary outcome was a 30-day composite outcome 
of all-cause mortality; significant rebleeding; an intervention 
to manage the bleeding; and intensive care unit (ICU) 
admission. Patients could experience multiple outcomes. We 
defined recurrent bleeding as a significant rebleeding (drop in 
hemoglobin, requiring blood transfusion or readmission) after 
24 hours of clinical stability that was objectively identified on 
physical examination or endoscopy after index visit disposition. 
Need for intervention was defined as receiving any of blood 
transfusion, undergoing endoscopic or surgical intervention, or 
having angiographic embolization to control the bleeding after 
the index visit.
Data Analysis
We calculated a sample size of 376 patients, based on a 
sensitivity of 95% and a bound on error of estimation between 
4%-5%.20 In order to include predictors in our preliminary 
model, we excluded variables with >25% of data missing, 
a cell count of ≤5, or a p-value >0.20 in the univariate 
analysis. We dichotomized the remainder of the variables 
based on clinical relevance and statistical significance. We 
then proceeded with multiple imputation with 10 datasets to 
account for missing data for variables with <25% missing 
data. We tested for collinearity and removed variables based 
on clinical and statistical significance. 
We performed logistic regression to identify risk 
factors and derive a preliminary model. We used a stepwise 
backward selection method with a p-value of <0.01 and the 
SELECTION=SCORE function in SAS software 9.4 (SAS 
Institute Inc., Cary, NC, USA). This method produces a model 
with a specific number of variables, which is useful when 
the number of outcomes is limited. We used Rubin’s rules 
to combine the estimates of the datasets from the multiple 
imputation database.21 
We developed a scoring system based on the point estimates 
of the odds ratios for the variables in the logistic regression 
analysis. Variables with a point estimate between 0.5 and 1.49 
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were assigned one point in the scoring system, and variables with 
a point estimate between 1.5 and 2.49 were assigned two points. 
We then calculated sensitivity, specificity, positive predictive value 
(PPV), negative predictive value (NPV), positive likelihood ratio 
(LR+), negative likelihood ratio (LR-) and area under the curve 
(AUC) with 95% confidence intervals (CI) per cut-off score. 
RESULTS
We identified 766 potential eligible patients and included 
372. See the Figure for a flow diagram. Outcomes were as 
follows: 61 patients (16.4%) suffered a serious outcome within 30 
days; 13 outcomes occurred in the ED (2.5%), while 48 (12.9%) 
happened after ED disposition. Four patients died, 12 experienced 
a recurrent bleeding, and 47 interventions were performed to stop 
the bleeding. 
Despite that the INR was only measured in 200 patients 
(53.8%), we reasoned that it was a clinically relevant variable 
and decided to use multiple imputations to deal with the missing 
data. We calculated the mean international normalized ratio 
(INR) for patients who were taking anticoagulants or diagnosed 
with liver cirrhosis (mean INR >2.0) and imputed this mean for 
patients with a missing INR who were on anticoagulants or had 
liver cirrhosis. We did the same for patients who were not on 
anticoagulants and did not have a liver disease (mean INR <2.0). 
Using the SELECTION=SCORE option in SAS on the 10 
datasets from the multiple imputation database, we found that 
the following five predictors were statistically significant in all 
10 datasets: age ≥75 years; INR ≥2.0; hemoglobin ≤100 grams 
per liter (g/L); clear red bloody stool in the ED; and past medical 
history of colorectal polyps. These results were similar using the 
backward selection method. 
We then assigned points to the variables based on the point 
estimates of the odds ratio derived from the logistic regression 
analysis (Appendix 1). Patients with a hemoglobin ≤100 g/L or 
INR ≥2.0 were assigned two points for each positive variable. 
Patients ≥75 years, who had a clear red bloody stool in the ED, 
or a past medical history of colorectal polyps were assigned one 
point for each positive variable. This added up to a maximum of 
seven points. When using a cut-off score of one, the sensitivity 
was 0.96 (95% CI, 0.90-1.00) and specificity was 0.53 (95% CI, 
0.48-0.59). The sensitivity decreased and specificity increased 
with a higher cut-off score. The AUC was 0.83 (95% CI, 
0.77-0.89) (Appendix 2). See the table for the classification 
performance of all possible cut-off scores. 
DISCUSSION
We found five predictors that could aid in risk-stratification 
of ED LGIB patients: age ≥75 years; INR ≥2.0; hemoglobin 
≤100 g/L; clear red bloody stool in the ED; and a past medical 
history of colorectal polyps. This model had a very good AUC 
(0.83, 95% CI, 0.77-0.89). The sensitivity and negative predictive 
value for a cut-off score of one are high, while the negative 
likelihood ratio is close to zero. Clinically, this means that 
patients with no risk factors are at very low risk to experience an 
outcome (Appendix 3). Therefore, this score could aid emergency 
physicians in identifying low-risk patients who can be managed 
in an outpatient setting, which could reduce the burden and 
associated costs on the healthcare system.
This score is an objective addition to clinical gestalt, 
as clinical gestalt is often influenced by patient-specific and 
physician-specific factors. As with all clinical decision rules, 
clinicians will use their judgment as to whether extenuating 
circumstances place a given patient at particularly high risk for a 
poor outcome despite the score placing them at low risk, or vice 
versa. Our priority was to develop a score that would identify 
low-risk patients, as we thought this would be most valuable to 
emergency physicians. However, we do acknowledge that ideally 
a risk score should identify both low-risk and high-risk patients, 
and all diagnostic accuracies should be high. 
LIMITATIONS
The data were retrospectively collected, which is not optimal 
for establishing a risk prediction model. However, most of the 
risk factors identified are reliably recorded, clearly understood 
clinical variables, which minimizes this limitation. We dealt with 
missing data by excluding variables with >25% missing data, and 
by using multiple imputations for variables with <25% missing 
data. INR had >25% missing data; however, we did not exclude 
it because it was thought to be a clinically relevant variable. We 
think INR was missed in so many patients as it is not always 
initially drawn and sometimes has to be added on to the blood 
work later. A future derivation study should be prospective with 
robust data collection to reduce the proportion of patients with 
missing data.
Another limitation is that we only had 48 adverse outcomes, 
which limits the number of predictors we could include in the 
final model. This is acceptable as it is a preliminary model, but 
a future study should include more patients and more adverse 
outcomes. Further, we used a composite outcome of death, 
recurrent bleeding, need for intervention, and ICU admission. 
This was based on previous GI bleed risk-stratification studies 
and allowed us to identify all high-risk and low-risk patients. 
We did not compare our data to clinical gestalt as our data were 
retrospectively collected. Future prospectively collected studies 
should compare the use of the risk score to clinical gestalt. 
CONCLUSION
In this retrospective cohort study, we identified five 
predictors that could aid in the risk-stratification of ED LGIB 
patients: age ≥75 years, INR ≥2.0; hemoglobin ≤100 g/L; 
clear red bloody stool in the ED; and a past medical history 
of colorectal polyps. Patients with high-risk criteria should 
be considered for timely management. Future, multicenter, 
prospective studies should be done to confirm our results, to 
externally validate the score, and to study the implementation of 
the score in clinical practice. 
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Potential eligible patient visits 
Number of charts screened
N=766 Excluded: n=394
• UGIB: n=168
• Other symptoms-no LGIB: n=106
• Non-acute LGIB: n=84
• Multiple patient visits: n=27
• Palliative care: n=5
• Transferred patients: n=3
• Non-Ottawa resident: n=1Included patients: 372
Outcomes*: n=48
• Death: n=4
• Recurrent bleeding: n=12
• Intervention: n=60 (in ED: 29)
• Blood transfusions: n=53
• In ED: 2
• Out of ED: 8
• Endoscopic intervention: 10
• In ED: n=2
• Out of ED: n=8
• Angiographic intervention: n=2
• Surgical intervention: n=2
• ICU admission: 6
• Vasopressors: n=1
• Respiratory failure: n=2
• Dialysis: n=0
Figure. Flow diagram of patient selection.
*Outcomes after ED disposition. Patients can experience multiple outcomes.
UGIB, upper gastrointestinal bleeding; LGIB, lower gastrointestinal bleeding; ED, emergency department; ICU, intensive care unit.
Cut-off scores*
Sensitivity 
(95% CI)
Specificity
(95% CI)
PPV
(95% CI)
NPV
(95% CI)
Positive LR
(95% CI)
Negative LR
(95% CI)
1 0.96
(0.90-1.00)
0.53
(0.48-0.59)
0.23
(0.17-0.29)
0.99
(0.97-1.00)
2.06
(1.80-2.34)
0.08
(0.02-0.30)
2 0.69
(0.55-0.82)
0.76
(0.70-0.81)
0.34
(0.25-0.44)
0.93
(0.89-0.97)
2.84
(2.11-3.82)
0.41
(0.26-0.64)
3 0.49
(0.35-0.63)
0.91
(0.86-0.94)
0.49
(0.35-0.63)
0.91
(0.86-0.94)
4.93
(3.06-7.97)
0.57
(0.43-0.75)
4 0.33
(0.20-0.47)
0.98
(0.97-1.00)
0.73
(0.54-0.91)
0.91
(0.88-0.94)
18.00
(7.41-44.00)
0.68
(0.56-0.83)
5 0.11
(0.00-0.23)
0.99
(0.98-1.00)
0.60
(0.17-1.00)
0.93
(0.89-0.95)
16.00
(2.80-92.00)
0.90
(0.78-1.02)
6 0.03
(0.00-0.06)
1.00
(1.00-1.00)
1.00
(1.00-1.00)
0.87
(0.84-0.91)
Inf
0.82-482.00
0.98
(0.92-1.02)
7†
Table. Diagnostic accuracies of the prediction model per cut-off score.
*The diagnostic accuracies are reported for the value of the cut-off score or higher
†0 patients had a score of 7
CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value; LR, likelihood ratio.
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